The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Drug Delivery to the Brain across the Blood–Brain Barrier Using Nanomaterials
Abstract
A major obstacle facing brain diseases such as Alzheimer's disease, multiple sclerosis, brain tumors, and strokes is the blood–brain barrier (BBB). The BBB prevents the passage of certain molecules and pathogens from the circulatory system into the brain. Therefore, it is nearly impossible for therapeutic drugs to target the diseased cells without the assistance of carriers. Nanotechnology is an area of growing public interest; nanocarriers, such as polymer‐based, lipid‐based, and inorganic‐based nanoparticles can be engineered in different sizes, shapes, and surface charges, and they can be modified with functional groups to enhance their penetration and targeting capabilities. Hence, understanding the interaction between nanomaterials and the BBB is crucial. In this Review, the components and properties of the BBB are revisited and the types of nanocarriers that are most commonly used for brain drug delivery are discussed. The properties of the nanocarriers and the factors that affect drug delivery across the BBB are elaborated upon in this review. Additionally, the most recent developments of nanoformulations and nonconventional drug delivery strategies are highlighted. Finally, challenges and considerations for the development of brain targeting nanomedicines are discussed. The overall objective is to broaden the understanding of the design and to develop nanomedicines for the treatment of brain diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery
Cheng, R., Meng, F., Deng, C., Klok, H.-A., & Zhong, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.084 · Cited by 1,354
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Intranasal delivery of biologics to the central nervous system
Lochhead, J. J., & Thorne, R. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.002 · Cited by 1,214
Receptor downregulation and multivesicular-body sorting
Katzmann, D. J., Odorizzi, G., & Emr, S. D. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm973 · Cited by 1,201
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis
Wang, T., Town, T., Alexopoulou, L., Anderson, J. F., Fikrig, E., & Flavell, R. A. (2004) · Nature Medicine · doi:10.1038/nm1140 · Cited by 1,155
Nanoparticulate systems for brain delivery of drugs.
Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922
Liposomal Drug Delivery Systems: An Update Review
Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 906
Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury
Shlosberg, D., Benifla, M., Kaufer, D., & Friedman, A. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.74 · Cited by 897
Georganopoulou, D. G., Chang, L., Nam, J.-M., Thaxton, C. S., Mufson, E. J., Klein, W. L., & Mirkin, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409336102 · Cited by 835
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 802
Microfluidics-based diagnostics of infectious diseases in the developing world
Chin, C. D., Laksanasopin, T., Cheung, Y. K., Steinmiller, D., Linder, V., Parsa, H., Wang, J., Moore, H., Rouse, R., Umviligihozo, G., et al. (2011) · Nature Medicine · doi:10.1038/nm.2408 · Cited by 759
Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability
Lockman, P. R., Koziara, J. M., Mumper, R. J., & Allen, D. D. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400015936 · Cited by 742
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium
Kolhar, P., Anselmo, A. C., Gupta, V., Pant, K., Prabhakarpandian, B., Ruoslahti, E., & Mitragotri, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308345110 · Cited by 646
Björkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine · doi:10.1038/nm1008 · Cited by 634
Inorganic nanoparticles for cancer imaging and therapy
Huang, H.-C., Barua, S., Sharma, G., Dey, S. K., & Rege, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.004 · Cited by 618
Sheikov, N., McDannold, N., Vykhodtseva, N., Jolesz, F., & Hynynen, K. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.04.010 · Cited by 617
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592
Insulin in the brain: There and back again
Banks, W. A., Owen, J. B., & Erickson, M. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.006 · Cited by 574
Wiley, D. T., Webster, P., Gale, A., & Davis, M. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307152110 · Cited by 519
A Review of Clinical Translation of Inorganic Nanoparticles
Anselmo, A. C., & Mitragotri, S. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9780-2 · Cited by 509
Receptor-Mediated Endocytosis of Nanoparticles of Various Shapes
Vácha, R., Martinez-Veracoechea, F. J., & Frenkel, D. (2011) · Nano Letters · doi:10.1021/nl2030213 · Cited by 494
Miura, Y., Takenaka, T., Toh, K., Wu, S., Nishihara, H., Kano, M. R., Ino, Y., Nomoto, T., Matsumoto, Y., Koyama, H., et al. (2013) · ACS Nano · doi:10.1021/nn402662d · Cited by 454
Transport of Steroid Hormones through the Rat Blood-Brain Barrier
Pardridge, W. M., & Mietus, L. J. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109433 · Cited by 444
Kubota, T., Kubota, N., Kumagai, H., Yamaguchi, S., Kozono, H., Takahashi, T., Inoue, M., Itoh, S., Takamoto, I., Sasako, T., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.018 · Cited by 435
Designing dendrimers for drug delivery
Liu, M., & Fréchet, J. M. J. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00203-5 · Cited by 434
Jo, D. H., Kim, J. H., Lee, T. G., & Kim, J. H. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.04.015 · Cited by 433
Active targeting of brain tumors using nanocarriers
Béduneau, A., Saulnier, P., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 424
Anatomy and physiology of the blood-brain barrier
Serlin, Y., Shelef, I., Knyazer, B., & Friedman, A. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.01.002 · Cited by 397
Cui, Y., Xu, Q., Chow, P. K.-H., Wang, D., & Wang, C.-H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.075 · Cited by 376
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
Bien-Ly, N., Yu, Y. J., Bumbaca, D., Elstrott, J., Boswell, C. A., Zhang, Y., Luk, W., Lu, Y., Dennis, M. S., Weimer, R. M., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131660 · Cited by 353
Quantitative analysis of drug delivery to the brain via nasal route
Kozlovskaya, L., Abou-Kaoud, M., & Stepensky, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.053 · Cited by 337
Evolution of macromolecular complexity in drug delivery systems
Kakkar, A., Traverso, G., Farokhzad, O. C., Weissleder, R., & Langer, R. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0063 · Cited by 320
Inorganic nanoparticles for biomedicine: where materials scientists meet medical research
Giner-Casares, J. J., Henriksen-Lacey, M., Coronado-Puchau, M., & Liz-Marzán, L. M. (2016) · Materials Today · doi:10.1016/j.mattod.2015.07.004 · Cited by 317
Li, Y., He, H., Jia, X., Lu, W.-L., Lou, J., & Wei, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.004 · Cited by 310
Bertazzo, S., Gentleman, E., Cloyd, K. L., Chester, A. H., Yacoub, M. H., & Stevens, M. M. (2013) · Nature Materials · doi:10.1038/nmat3627 · Cited by 293
Cheng, K. K., Chan, P. S., Fan, S., Kwan, S. M., Yeung, K. L., Wáng, Y.-X. J., Chow, A. H. L., Wu, E. X., & Baum, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.005 · Cited by 293
Caminade, A.-M., & Turrin, C.-O. (2014) · J. Mater. Chem. B · doi:10.1039/c4tb00171k · Cited by 290
Christian, D. A., Cai, S., Garbuzenko, O. B., Harada, T., Zajac, A. L., Minko, T., & Discher, D. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900022m · Cited by 289
Nair, M., Guduru, R., Liang, P., Hong, J., Sagar, V., & Khizroev, S. (2013) · Nature Communications · doi:10.1038/ncomms2717 · Cited by 287
Clark, A. J., & Davis, M. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517048112 · Cited by 280
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Zhou, J., Patel, T. R., Sirianni, R. W., Strohbehn, G., Zheng, M.-Q., Duong, N., Schafbauer, T., Huttner, A. J., Huang, Y., Carson, R. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304504110 · Cited by 271
Jiang, X., Xin, H., Ren, Q., Gu, J., Zhu, L., Du, F., Feng, C., Xie, Y., Sha, X., & Fang, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.094 · Cited by 270
Fan, Q., Cheng, K., Yang, Z., Zhang, R., Yang, M., Hu, X., Ma, X., Bu, L., Lu, X., Xiong, X., et al. (2015) · Advanced Materials · doi:10.1002/adma.201402972 · Cited by 264
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Zhang, C., Wan, X., Zheng, X., Shao, X., Liu, Q., Zhang, Q., & Qian, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.063 · Cited by 262
Nance, E., Timbie, K., Miller, G. W., Song, J., Louttit, C., Klibanov, A. L., Shih, T.-Y., Swaminathan, G., Tamargo, R. J., Woodworth, G. F., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.031 · Cited by 252
Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting
Liu, Y., Ran, R., Chen, J., Kuang, Q., Tang, J., Mei, L., Zhang, Q., Gao, H., Zhang, Z., & He, Q. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.031 · Cited by 246
Lee, C., Hwang, H. S., Lee, S., Kim, B., Kim, J. O., Oh, K. T., Lee, E. S., Choi, H., & Youn, Y. S. (2017) · Advanced Materials · doi:10.1002/adma.201605563 · Cited by 246
Progress and problems in the application of focused ultrasound for blood–brain barrier disruption
Vykhodtseva, N., McDannold, N., & Hynynen, K. (2008) · Ultrasonics · doi:10.1016/j.ultras.2008.04.004 · Cited by 245
Kanazawa, T., Akiyama, F., Kakizaki, S., Takashima, Y., & Seta, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.036 · Cited by 241
Glangchai, L. C., Caldorera-Moore, M., Shi, L., & Roy, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.021 · Cited by 239
Physical and Chemical Strategies for Therapeutic Delivery by Using Polymeric Nanoparticles
Morachis, J. M., Mahmoud, E. A., & Almutairi, A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005363 · Cited by 238
Magnetic targeting of nanoparticles across the intact blood–brain barrier
Kong, S. D., Lee, J., Ramachandran, S., Eliceiri, B. P., Shubayev, V. I., Lal, R., & Jin, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.021 · Cited by 226
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma
Zhang, B., Sun, X., Mei, H., Wang, Y., Liao, Z., Chen, J., Zhang, Q., Hu, Y., Pang, Z., & Jiang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.039 · Cited by 225
Glioma targeting and blood–brain barrier penetration by dual-targeting doxorubincin liposomes
Gao, J.-Q., Lv, Q., Li, L.-M., Tang, X.-J., Li, F.-Z., Hu, Y.-L., & Han, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.097 · Cited by 224
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie · doi:10.1002/ange.200250653 · Cited by 221
Kim, J.-Y., Choi, W. I., Kim, Y. H., & Tae, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.047 · Cited by 219
Fornaguera, C., Dols-Perez, A., Calderó, G., García-Celma, M. J., Camarasa, J., & Solans, C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.002 · Cited by 218
Liu, Z., Jiang, M., Kang, T., Miao, D., Gu, G., Song, Q., Yao, L., Hu, Q., Tu, Y., Pang, Z., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.003 · Cited by 217
Krol, S., Macrez, R., Docagne, F., Defer, G., Laurent, S., Rahman, M., Hajipour, M. J., Kehoe, P. G., & Mahmoudi, M. (2013) · Chemical Reviews · doi:10.1021/cr200472g · Cited by 216
Gene and doxorubicin co-delivery system for targeting therapy of glioma
Liu, S., Guo, Y., Huang, R., Li, J., Huang, S., Kuang, Y., Han, L., & Jiang, C. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.031 · Cited by 203
Liu, Y., An, S., Li, J., Kuang, Y., He, X., Guo, Y., Ma, H., Zhang, Y., Ji, B., & Jiang, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.060 · Cited by 188
Costa, P. M., Cardoso, A. L., Custódia, C., Cunha, P., Pereira de Almeida, L., & Pedroso de Lima, M. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.002 · Cited by 187
Sharma, G., Modgil, A., Layek, B., Arora, K., Sun, C., Law, B., & Singh, J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.016 · Cited by 184
Byeon, H. J., Thao, L. Q., Lee, S., Min, S. Y., Lee, E. S., Shin, B. S., Choi, H.-G., & Youn, Y. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.046 · Cited by 179
Hu, Q., Gao, X., Gu, G., Kang, T., Tu, Y., Liu, Z., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.025 · Cited by 174
Chung, S., Ginger, D. S., Morales, M. W., Zhang, Z., Chandrasekhar, V., Ratner, M. A., & Mirkin, C. A. (2005) · Small · doi:10.1002/smll.200400005 · Cited by 173
Yin, T., Wang, P., Li, J., Zheng, R., Zheng, B., Cheng, D., Li, R., Lai, J., & Shuai, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.067 · Cited by 172
Gonzalez-Carter, D. A., Leo, B. F., Ruenraroengsak, P., Chen, S., Goode, A. E., Theodorou, I. G., Chung, K. F., Carzaniga, R., Shaffer, M. S. P., Dexter, D. T., et al. (2017) · Scientific Reports · doi:10.1038/srep42871 · Cited by 170
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier
Dal Magro, R., Ornaghi, F., Cambianica, I., Beretta, S., Re, F., Musicanti, C., Rigolio, R., Donzelli, E., Canta, A., Ballarini, E., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.039 · Cited by 165
Li, X.-Y., Zhao, Y., Sun, M.-G., Shi, J.-F., Ju, R.-J., Zhang, C.-X., Li, X.-T., Zhao, W.-Y., Mu, L.-M., Zeng, F., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.049 · Cited by 163
Chen, C. C., Sheeran, P. S., Wu, S.-Y., Olumolade, O. O., Dayton, P. A., & Konofagou, E. E. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.025 · Cited by 163
Dual targeted nanocarrier for brain ischemic stroke treatment
Zhao, Y., Jiang, Y., Lv, W., Wang, Z., Lv, L., Wang, B., Liu, X., Liu, Y., Hu, Q., Sun, W., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.038 · Cited by 162
Lherm, C., Müller, R. H., Puisieux, F., & Couvreur, P. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90210-s · Cited by 159
Mittal, G., Carswell, H., Brett, R., Currie, S., & Kumar, M. N. V. R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.013 · Cited by 158
Theranostic USPIO‐Loaded Microbubbles for Mediating and Monitoring Blood‐Brain Barrier Permeation
Lammers, T., Koczera, P., Fokong, S., Gremse, F., Ehling, J., Vogt, M., Pich, A., Storm, G., van Zandvoort, M., & Kiessling, F. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201401199 · Cited by 156
Mead, B. P., Mastorakos, P., Suk, J. S., Klibanov, A. L., Hanes, J. S., & Price, R. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.034 · Cited by 155
Bioavailability and Transport of Peptides and Peptide Drugs into the Brain
Egleton, R. D., & Davis, T. P. (1997) · Peptides · doi:10.1016/s0196-9781(97)00242-8 · Cited by 153
Kafa, H., Wang, J. T.-W., Rubio, N., Klippstein, R., Costa, P. M., Hassan, H. A. F. M., Sosabowski, J. K., Bansal, S. S., Preston, J. E., Abbott, N. J., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.031 · Cited by 153
Miner, J. J., Daniels, B. P., Shrestha, B., Proenca-Modena, J. L., Lew, E. D., Lazear, H. M., Gorman, M. J., Lemke, G., Klein, R. S., & Diamond, M. S. (2015) · Nature Medicine · doi:10.1038/nm.3974 · Cited by 152
Pardridge, W. M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.952627 · Cited by 152
Liposome-based glioma targeted drug delivery enabled by stable peptide ligands
Wei, X., Gao, J., Zhan, C., Xie, C., Chai, Z., Ran, D., Man, Y. M., Zheng, P., & Lu, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.059 · Cited by 146
Liu, X., Sui, B., & Sun, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.006 · Cited by 143
Aryal, M., Vykhodtseva, N. I., Zhang, Y., & McDannold, N. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.033 · Cited by 139
Quader, S., Liu, X., Chen, Y., Mi, P., Chida, T., Ishii, T., Miura, Y., Nishiyama, N., Cabral, H., & Kataoka, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.033 · Cited by 139
Park, T., Singh, B., Li, H.-S., Lee, J.-Y., Kang, S., Choi, Y., & Cho, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.068 · Cited by 136
Xin, H., Sha, X., Jiang, X., Chen, L., Law, K., Gu, J., Chen, Y., Wang, X., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.018 · Cited by 135
Timbie, K. F., Afzal, U., Date, A. A., Zhang, C., Song, J. S., Miller, G. W., Suk, J. S., Hanes, J. S., & Price, R. J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.017 · Cited by 135
Zhang, C., Nance, E. A., Mastorakos, P., Chisholm, J., Berry, S., Eberhart, C. G., Tyler, B., Brem, H., Suk, J. S., & Hanes, J. S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.007 · Cited by 134
Das, D., & Lin, S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20357 · Cited by 117
Zhang, R., Li, Y., Hu, B., Lu, Z., Zhang, J., & Zhang, X. (2016) · Advanced Materials · doi:10.1002/adma.201600554 · Cited by 116
Self-citationEffect of PLGA NP size on efficiency to target traumatic brain injury
Cruz, L. J., Stammes, M. A., Que, I., van Beek, E. R., Blankevoort, V., Snoeks, T. J. A., Chan, A. B., Kaijzel, E. L., & Löwik, C. W. G. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.029 · Cited by 115
Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles
Lu, Y., Huang, J.-Y., Wang, H., Lou, X.-F., Liao, M.-H., Hong, L.-J., Tao, R., Ahmed, M. M., Shan, C.-L., Wang, X.-L., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.093 · Cited by 113
Yao, H., Wang, K., Wang, Y., Wang, S., Li, J., Lou, J., Ye, L., Yan, X., Lu, W., & Huang, R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.034 · Cited by 109
Marie, H., Lemaire, L. P., Franconi, F., Lajnef, S., Frapart, Y., Nicolas, V., Frébourg, G., Trichet, M., Ménager, C., & Lesieur, S. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201402289 · Cited by 108
Du, D., Chang, N., Sun, S., Li, M., Yu, H., Liu, M., Liu, X., Wang, G., Li, H., Liu, X., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.006 · Cited by 106
Huang, H.-Y., Liu, H., Hsu, P., Chiang, C., Tsai, C., Chi, H., Chen, S., & Chen, Y. (2014) · Advanced Materials · doi:10.1002/adma.201403889 · Cited by 106
Zhang, C., Zheng, X., Xu, W., Shao, X., Liu, Q., Zhang, Z., & Zhang, Q. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.050 · Cited by 106
Kirschbaum, K., Sonner, J. K., Zeller, M. W. G., Deumelandt, K., Bode, J., Sharma, R. K., Krüwel, T., Fischer, M. D., Hoffmann, A., da Silva, M. C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609397113 · Cited by 106
In vivo delivery of siRNA to the brain by carbosilane dendrimer
Serramía, M. J., Álvarez, S., Fuentes‐Paniagua, E., Clemente, M. I., Sánchez‐Nieves, J., Gómez, R., de la Mata, J., & Muñoz‐Fernández, M. Á. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.042 · Cited by 105
Dilnawaz, F., Singh, A., Mewar, S., Sharma, U., Jagannathan, N. R., & Sahoo, S. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.046 · Cited by 103
The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain
Sharma, G., Lakkadwala, S., Modgil, A., & Singh, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060806 · Cited by 103
Chen, Y., Chiang, C., Chen, L., Liang, P., Hsieh, W., & Lin, W.-L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.042 · Cited by 102
Cao, C., Wang, X., Cai, Y., Sun, L., Tian, L., Wu, H., He, X., Lei, H. C., Liu, W., Chen, G., et al. (2014) · Advanced Materials · doi:10.1002/adma.201304544 · Cited by 101
Qian, Y. J., Zha, Y., Feng, B. C., Pang, Z., Zhang, B., Sun, X., Ren, J., Zhang, C., Shao, X., Zhang, Q., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.050 · Cited by 99
Wang, G., Wang, J., Chen, X.-L., Du, L., & Li, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.045 · Cited by 99
Bharadwaj, V. N., Lifshitz, J., Adelson, P. D., Kodibagkar, V. D., & Stabenfeldt, S. E. (2016) · Scientific Reports · doi:10.1038/srep29988 · Cited by 94
Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain
Somani, S., Blatchford, D. R., Millington, O. R., Stevenson, M. L., & Dufès, C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.006 · Cited by 93
Yang, H., Hua, M., Hwang, T., Lin, K., Huang, C., Tsai, R., Ma, C.-C. M., Hsu, P., Wey, S., Hsu, P., et al. (2013) · Advanced Materials · doi:10.1002/adma.201301046 · Cited by 92
Cai, X., Bandla, A., Mao, D., Feng, G., Qin, W., Liao, L., Thakor, N. V., Tang, B. Z., & Liu, B. (2016) · Advanced Materials · doi:10.1002/adma.201601191 · Cited by 92
Zhang, F., Magruder, J. T., Lin, Y.-A., Crawford, T. C., Grimm, J. C., Sciortino, C. M., Wilson, M. A., Blue, M. E., Kannan, S., Johnston, M. V., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.032 · Cited by 92
Belhadj, Z., Man, Y. M., Cao, X., Hu, X., Zhan, C., Wei, X., Gao, J., Wang, X., Yan, Z., & Lu, W. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.006 · Cited by 91
SiO2 nanoparticles change colour preference and cause Parkinson's-like behaviour in zebrafish
Li, X., Лю, Б., Li, X.-L., Li, Y.-X., Sun, M., Chen, D.-Y., Zhao, X. J., & Feng, X. (2014) · Scientific Reports · doi:10.1038/srep03810 · Cited by 88
Jiang, X., Sha, X., Xin, H., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.049 · Cited by 85
Qian, L., Zheng, J., Wang, K., Tang, Y., Zhang, X., Zhang, H., Huang, F., Pei, Y., & Jiang, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.097 · Cited by 85
Self-citationShi, P., Li, M. C., Ren, J., & Qu, X. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201301015 · Cited by 83
Gao, S., Tian, H., Xing, Z., Zhang, D., Guo, Y., Guo, Z., Zhu, X., & Chen, X. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.027 · Cited by 83
Zhang, Y., Buttry, J. L., Minić, Ž., Liu, F., Goshgarian, H. G., & Mao, G. (2016) · Scientific Reports · doi:10.1038/srep25794 · Cited by 77
Kolter, M., Ott, M., Hauer, C., Reimold, I., & Fricker, G. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.005 · Cited by 75
Åslund, A., Berg, S., Hak, S., Mørch, Y. A., TORP, S. H., Sandvig, A., Widerøe, M., Hansen, R., & Davies, C. D. L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.047 · Cited by 72
NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo
Carradori, D., Saulnier, P., Véronique Préat, A., Rieux, A. D., & Eyer, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.006 · Cited by 72
Herrán, E., Pérez‐González, R., Igartúa, M., Pedraz, J. L., Carro, E., & Hernández, R. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.028 · Cited by 70
Jenkins, S. I., Weinberg, D., al-Shakli, A. F., Fernandes, A. R., Yiu, H. H. P., Telling, N. D., Roach, P., & Chari, D. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.013 · Cited by 70
Crossing the blood-brain barrier: Glutathione-conjugated poly(ethylene imine) for gene delivery
Englert, C., Trützschler, A., Raasch, M., Buś, T., Borchers, P., Mosig, A. S., Traeger, A., & Schubert, U. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.039 · Cited by 68
Non-invasive aerosol delivery and transport of gold nanoparticles to the brain
Raliya, R., Saha, D., Chadha, T. S., Raman, B., & Biswas, P. (2017) · Scientific Reports · doi:10.1038/srep44718 · Cited by 67
Mulik, R. S., Bing, C., Ladouceur-Wodzak, M., Munaweera, I., Chopra, R., & Corbin, I. R. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.021 · Cited by 63
Wang, B., Lv, L., Wang, Z., Jiang, Y., Lv, W., Liu, X., Wang, Z., Zhao, Y., Xin, H., & Xu, Q. (2015) · Scientific Reports · doi:10.1038/srep16589 · Cited by 63
Zeng, L., Zou, L., Yu, H., He, X., Cao, H., Zhang, Z., Yin, Q., Zhang, P., Gu, W., Chen, L., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600642 · Cited by 61
Gao, W., Liu, Y., Jing, G.-X., Li, K., Zhao, Y., Sha, B., Wang, Q., & Wu, D. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.045 · Cited by 56
Somani, S., Robb, G., Pickard, B. S., & Dufès, C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.003 · Cited by 54
Yao, L., Song, Q., Bai, W., Zhang, J., Miao, D., Jiang, M., Wang, Y., Shen, Z., Hu, Q., Gu, X. Q., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.043 · Cited by 54
Yi, X., Yuan, D., Farr, S. A., Banks, W. A., Poon, C., & Kabanov, A. V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.044 · Cited by 50
Hemmelmann, M., Metz, V. V., Koynov, K., Blank, K. G., Postina, R., & Zentel, R. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.034 · Cited by 48
Brown, A., Patel, S., Ward, C., Lorenz, A. S., Ortiz, M., DuRoss, A. N., Wieghardt, F., Esch, A. M., Otten, E. G., Heiser, L. M., et al. (2016) · Scientific Reports · doi:10.1038/srep31750 · Cited by 48
Smith, N. M., Gachulincová, I., Ho, D., Bailey, C. S. L., Bartlett, C. A., Nörret, M., Murphy, J., Buckley, A. G., Rigby, P. J., House, M. J., et al. (2016) · Scientific Reports · doi:10.1038/srep22595 · Cited by 44
Shevtsov, M. A., Parr, M. A., Ryzhov, V. A., Zemtsova, E. G., Arbenin, A. Y., Ponomareva, A. N., Смирнов, В. М., & Multhoff, G. (2016) · Scientific Reports · doi:10.1038/srep29247 · Cited by 41
Wang, J., Yang, Y., Zhang, Y., Huang, M., Zhou, Z.-J., Luo, W., Tang, J., Wang, J., Xiao, Q., Chen, H., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201602810 · Cited by 39
Chaturbedy, P., Kumar, M., Salikolimi, K., Das, S., Sinha, S. H., Chatterjee, S., Suma, B. S., Kundu, T. K., & Eswaramoorthy, M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.043 · Cited by 36
Block Copolymer Micelles for Nanomedicine
Li, W., Feng, S., & Guo, Y. (2012) · Nanomedicine · doi:10.2217/nnm.11.182 · Cited by 32
Gao, X., Tsou, Y., Garis, M., Huang, H., & Xu, X. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.05.011 · Cited by 12
Self-citation
Cited by
Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies
Ding, S., Khan, A. I., Cai, X., Song, Y., Lyu, Z., Du, D., Dutta, P., & Lin, Y. (2020) · Materials Today · doi:10.1016/j.mattod.2020.02.001 · Cited by 440
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378
De, R., Mahata, M. K., & Kim, K. (2022) · Advanced Science · doi:10.1002/advs.202105373 · Cited by 297
Brown, T. D., Habibi, N., Wu, D., Lahann, J., & Mitragotri, S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00743 · Cited by 182
Nguyen, D. D., & Lai, J.-Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134970 · Cited by 178
Metadata
- Authors
- Tsou, Y., Zhang, X., Zhu, H., Syed, S., & Xu, X.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2017-10-16
- Volume
- 13
- Issue
- 43
- Pages
- e1801588-e1801588
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2766538795
- Cited by
- 258
- References
- 157
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.